ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

NCI To Expand Funds for Cancer Centers, SPOREs, Director Tells House Appropriators

March 29, 2002

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

Congress Close to Approving Appropriations for FY 1985

September 14, 1984

Tumor Treating Fields Therapy Increased Three-Year Survival

November 25, 2011